Hormone replacement therapy increases risk for GI cancers in postmenopausal women

CHICAGO — The odds of having gastric and pancreatic cancers were higher among postmenopausal women on hormone replacement therapy and remained significant after controlling for risk factors, according to data at Digestive Disease Week.“In the United States, approximately 40% of postmenopausal women use hormone replacement therapy (HRT) — estrogen with or without progesterone,” Somtochukwu Onwuzo, MD, an internal medicine resident at Cleveland Clinic, told Healio. “Over the years, results for most studies showing benefits of HRT were only significant forRead More